Sub Banner Image

Summit Falls After Lung Cancer Data Disappoints Wall Street

Markets

Gerry Smith, Amber Tong

·

September 8, 2025

·

Bloomberg

Summit Therapeutics Inc.’s shares plummeted after new data cast doubt on the future of its closely-watched lung cancer drug.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.